Cover Image

Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long‐term risk of cardiovascular events and mortality

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Fei Chen, Yifan He, Jinping Wang, Liping Yu, Qiuhong Gong, Yanyan Chen, Yali An, Siyao He, Guangwei Li, Bo Zhang
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of 1‐hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes‐related complications: A post hoc analysis of the 30‐year follow‐up of the Da Qing IGT and Diabetes Study
by: Minying Peng, et al.
Published: (2024)

Association of gestational diabetes with long‐term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank
by: Moscho Michalopoulou, et al.
Published: (2024)

Beta cell function and global glucose metabolism are impaired in Dp(16)1Yey mouse model of Down syndrome
by: Stefania Tolu, et al.
Published: (2025)

Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
by: Pareeta Kotecha, et al.
Published: (2024)

Association of metabolic score for visceral fat with all‐cause mortality, cardiovascular mortality, and cancer mortality: A prospective cohort study
by: Shanshan Jia, et al.
Published: (2024)

Association of cumulative exposure to cholesterol, high‐density lipoprotein, and glucose index with the risk of cardiovascular disease and all‐cause mortality: A longitudinal cohort study
by: Ruobing Tian, et al.
Published: (2025)

The combined effect of triglyceride–glucose index and high‐sensitivity C‐reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study
by: Qinxue Li, et al.
Published: (2024)

A biweekly DPP ‐4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial
by: Qinghua He, et al.
Published: (2024)

Associations of fasting plasma glucose with all‐cause mortality and cardiovascular events in older Chinese diabetes patients: A population‐based cohort study
by: Linan Wang, et al.
Published: (2024)

Association between metabolic syndrome and risk of cardiovascular disease among postmenopausal women: A cohort study
by: Jintao Tao, et al.
Published: (2025)

The impact of sodium‐glucose co‐transporter‐2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation
by: Yun‐Yu Chen, et al.
Published: (2024)

The circadian syndrome is a predictor for cognition impairment in middle‐aged adults: Comparison with the metabolic syndrome
by: Zumin Shi, et al.
Published: (2024)

Fasting blood glucose level and risk of all‐cause and cause‐specific mortality in peritoneal dialysis patients
by: So Jin Lim, et al.
Published: (2024)

An open‐label study on ulotaront's effects on insulin‐glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I
by: Snezana Milanovic, et al.
Published: (2025)

Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome
by: Jasraj Singh, et al.
Published: (2024)

Biomarkers for cardiovascular–kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment
by: Kevin Yau, et al.
Published: (2025)

Assessment of triglyceride‐glucose composite indices associated mortality risk in diabetes‐related heart failure
by: Qijie Zhao, et al.
Published: (2026)

GLP ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
by: Tommaso Bucci, et al.
Published: (2025)

Arterial stiffness and atherosclerosis and incident cardiovascular events and all‐cause mortality in individuals with manifest cardiovascular disease with and without type 2 diabetes
by: Jan F. de Leijer, et al.
Published: (2025)

The effects of antihypertensive drugs on glucose metabolism
by: Zhe Li, et al.
Published: (2024)

An update and overview of the various health‐related benefits of probiotics: A focus on clinical trials demonstrating efficacy, tolerability and use in patients with impaired glucose tolerance and type 2 diabetes
by: Takayuki Toshimitsu, et al.
Published: (2025)

Longitudinal trajectories of fasting plasma glucose predicting cardiovascular disease risk in Chinese patients with type 2 diabetes under health management
by: Shijun Liu, et al.
Published: (2025)

Explainable machine learning‐driven predictive modelling of incident cognitive impairment in individuals with early‐stage cardiovascular–kidney–metabolic syndrome: Insights from a longitudinal CHARLS cohort study
by: Shoupeng Duan, et al.
Published: (2025)

Glucagon‐like peptide‐1 receptor agonists lower risk of cardiovascular and non‐cardiovascular mortality: A meta‐analysis of eleven cardiovascular outcome trials
by: Yu Mi Kang, et al.
Published: (2025)

The long‐term effect of bariatric/metabolic surgery versus pharmacologic therapy in type 2 diabetes mellitus patients: A systematic review and meta‐analysis
by: Yumeng Yang, et al.
Published: (2024)

The roles of output clock genes in regulating glucose metabolism
by: Akihiko Taguchi, et al.
Published: (2024)

Biomedical outcomes and cardiovascular risks in Chinese adults with type 2 diabetes in the metabolic management center program: A longitudinal comparative study
by: Zhanpeng He, et al.
Published: (2025)

Higher dietary magnesium intake and lower risks of all‐cause, cardiovascular and kidney disease mortality in diabetes participants: A large cross‐population cohort study
by: Kaiyi Chi, et al.
Published: (2026)

Diagnostic differences in glycemic markers for detecting impaired glucose tolerance in Black African and White European men in the United Kingdom: The SOUL ‐ DEEP cross‐sectional study
by: Louise M. Goff, et al.
Published: (2026)

Ceramide‐based risk score CERT‐1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study
by: Alessandro Mantovani, et al.
Published: (2024)

Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea
by: Hwa Yeon Ko, et al.
Published: (2025)

Regulation of glucose and energy metabolism through actions of glucagon‐like peptide‐1 and glucose‐dependent insulinotropic polypeptide
by: Yasuo Zenimaru, et al.
Published: (2024)

Associations of metabolic syndrome with cognitive function and dementia risk: Evidence from the UK Biobank cohort
by: Qianlin Zuo, et al.
Published: (2024)

A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy
by: Filip K. Knop, et al.
Published: (2024)

Clinical risk phenotypes in diabetes and their associations with adverse cardiovascular events: A report from the Silesia Diabetes‐Heart Project
by: Marta Mantovani, et al.
Published: (2025)

Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome
by: Steven K. Malin, et al.
Published: (2026)

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes
by: Shujun Zhang, et al.
Published: (2024)

Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS
by: Soroush Masrouri, et al.
Published: (2024)

Association of GLP1 ‐receptor agonist use with liver disease progression, major cardiovascular events, and mortality in people with hepatic steatosis and diabetes
by: Suleiman Al Ashi, et al.
Published: (2025)

Serum CTRP3 and CysC correlate with glucose, lipid, and bone metabolism in elderly patients with type 2 diabetes mellitus complicated with osteoporosis
by: Yi‐Peng Wang, et al.
Published: (2026)